Pages that link to "Q70934928"
Jump to navigation
Jump to search
The following pages link to Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study (Q70934928):
Displaying 19 items.
- Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study (Q33390403) (← links)
- Diagnosis and management of psoriatic arthritis (Q34158095) (← links)
- Spondylarthropathies: options for combination therapy (Q34309710) (← links)
- Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. (Q34560557) (← links)
- Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up (Q35551412) (← links)
- A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis (Q35555637) (← links)
- Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004. (Q35579352) (← links)
- Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. (Q35579450) (← links)
- Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005 (Q35579517) (← links)
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. (Q35638252) (← links)
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritis (Q36096798) (← links)
- Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review (Q36139268) (← links)
- Psoriatic arthritis: current topics (Q37051500) (← links)
- Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritid (Q37679286) (← links)
- The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review (Q38925320) (← links)
- Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis (Q74545287) (← links)
- [Therapy for secondary arthropathies: from psoriasis and Reiter's disease to hemochromatosis] (Q79356110) (← links)
- Update on the treatment of peripheral arthritis in psoriatic arthritis (Q84430488) (← links)
- Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy (Q85054900) (← links)